Investing Center Preview – Manage your investments and watch your net worth grow.
A:NYSE – Large Cap Stock (Diagnostics & Research)
Agilent Technologies Inc – A Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
113.93 | -0.12 (-0.11%) | 112.75 - 155.35 | 213.8 thousand (Below Avg) |
Market data as of 10:19AM 04/02/25. Quotes are delayed by at least 15 min.
Overview - A
Open | 113.54 |
---|---|
Previous Close | 114.05 |
Day's Range | 112.75 - 114.56 |
Market Cap | 32.5B |
Avg Volume (10 Day) | 2.1M |
Price/Earnings (Trailing 12 Mo.) | 26.8x |
Earnings Per Share (Trailing 12 Mo.) | 1.674 |
Dividend Yield | 0.248 (0.87%) |
One-Click Scorecard - A


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Pass |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Pass |
Increased shareholder value? | Fail |
Consistently increased owner earnings? | Pass |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Pass |
---|---|
Room to increase dividends? | Pass |
Increased earnings over time? | Pass |
Borrows within reasonable limits? | Fail |
Stock is undervalued? | Fail |
Have investors caught on? | Fail |
Has support of institutional investors? | Pass |
Has sufficient liquidity? | Pass |
Latest Headlines - A
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
Business Wire - Monday 03/24/2025 8:00 AM ET
CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
Business Wire - Thursday 03/20/2025 8:00 AM ET
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
Business Wire - Wednesday 03/19/2025 8:00 AM ET
Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications
Business Wire - Monday 03/10/2025 8:19 AM ET
Industry Position - A
A | Industry Range | |
---|---|---|
Revenue Growth (1yr) | -4.73% | |
Net Income Growth (1yr) | 3.95% | |
Total Debt/Equity | 0.56 | |
LT Debt/Equity | 0.56 | |
Earnings Yield | 3.73% | |
Price/Sales | 5.18 |
Competitors - A
Company | Last | Change |
---|---|---|
IDEXX Laboratories Inc | 417.25 | -0.32% |
IQVIA Holdings Inc | 170.56 | -0.40% |
717.00 | -0.69% | |
3205.00 | -4.47% | |
1008.75 | +5.20% |
Data is delayed by at least 15 min.